Literature DB >> 33532132

Ischemic Conditioning Ameliorated Hypertension and Vascular Remodeling of Spontaneously Hypertensive Rat via Inflammatory Regulation.

Yu Gao1,2, Changhong Ren2,3, Xiaohua Li2,3, Wantong Yu1, Sijie Li2,3, Haiyan Li2, Yan Wang2, Dong Li4, Ming Ren1, Xunming Ji1,5.   

Abstract

Vascular remodeling is an initial step in the development of hypertension. Limb remote ischemic conditioning (LRIC) is a physiological treatment that induces endogenous protective effect during acute ischemic injury. However, the impact of long-term LRIC on hypertension, a chronic disease, is unknown. In this study, we aimed to investigate the LRIC effect on blood pressure and vascular remodeling in spontaneously hypertensive rat (SHR) model and patients with prehypertension and early-stage hypertension. LRIC of rats was performed once a day for 6-weeks. Blood pressure, vascular remodeling (cross-sectional area, extracellular deposition, and smooth muscle cell area), inflammation (inflammatory factors, and inflammatory cells) were compared among normotensive Wistar-Kyoto rats (WKY), WKY RIC group, SHR control group, and SHR RIC. Long-term LRCI treatment (twice a day for 4-weeks) was performed on patients with prehypertension or early-stage hypertension. Blood pressure and pulse wave velocity (PWV) were analyzed before and after LRIC treatment. LRIC treatment decreased blood pressure in SHR (n = 9-10). LRIC ameliorated vascular remodeling by decreasing cross-sectional area, suppressing deposition of the extracellular matrix, and hypertrophy of smooth muscle cell in conduit artery and small resistance artery (n = 7). LRIC decreased proinflammatory factors while increasing the anti-inflammatory factors in the circulation (n = 5). LRIC decreased circulating monocyte and natural killer T-cell levels (n = 5). Furthermore, LRIC treatment decreased blood pressure and improved vascular stiffness in patients (n = 20). In conclusion, long term LRIC could decrease blood pressure and ameliorate vascular remodeling via inflammation regulation. LRIC could be a preventive treatment for people with blood pressure elevation or prehypertension. copyright:
© 2021 Gao et al.

Entities:  

Keywords:  hypertension; inflammation; limb remote ischemic preconditioning; vascular remodeling

Year:  2021        PMID: 33532132      PMCID: PMC7801289          DOI: 10.14336/AD.2020.0320

Source DB:  PubMed          Journal:  Aging Dis        ISSN: 2152-5250            Impact factor:   6.745


  6 in total

1.  Remote ischemic conditioning causes CD4 T cells shift towards reduced cell-mediated inflammation.

Authors:  Mashriq Alganabi; George Biouss; Niloofar Ganji; Masaya Yamoto; Carol Lee; Bo Li; Agostino Pierro
Journal:  Pediatr Surg Int       Date:  2022-03-04       Impact factor: 1.827

Review 2.  Hypoxic/Ischemic Inflammation, MicroRNAs and δ-Opioid Receptors: Hypoxia/Ischemia-Sensitive Versus-Insensitive Organs.

Authors:  Yimeng Chen; Yichen He; Shuchen Zhao; Xiaozhou He; Dong Xue; Ying Xia
Journal:  Front Aging Neurosci       Date:  2022-05-09       Impact factor: 5.702

Review 3.  Chronic Limb Remote Ischemic Conditioning may have an Antihypertensive Effect in Patients with Hypertension.

Authors:  Wenting Guo; Changhong Ren; Bowei Zhang; Wenbo Zhao; Yu Gao; Wantong Yu; Xunming Ji
Journal:  Aging Dis       Date:  2021-12-01       Impact factor: 6.745

4.  Daily Remote Ischemic Conditioning Can Improve Cerebral Perfusion and Slow Arterial Progression of Adult Moyamoya Disease-A Randomized Controlled Study.

Authors:  Jiali Xu; Qian Zhang; Gary B Rajah; Wenbo Zhao; Fang Wu; Yuchuan Ding; Bowei Zhang; Wenting Guo; Qi Yang; Xiurong Xing; Sijie Li; Xunming Ji
Journal:  Front Neurol       Date:  2022-02-03       Impact factor: 4.003

5.  Periodontitis Is Associated With Heart Failure: A Population-Based Study (NHANES III).

Authors:  Yan Yan; Min Mao; Yan-Qin Li; Yong-Ji Chen; He-Dong Yu; Wen-Zhong Xie; Qiao Huang; Wei-Dong Leng; Jie Xiong
Journal:  Front Physiol       Date:  2022-04-20       Impact factor: 4.755

6.  Effects of remote ischemic conditioning on sleep complaints in Parkinson's disease-rationale, design, and protocol for a randomized controlled study.

Authors:  Qiling Ji; Xuemei Wang; Wenbo Zhao; Melissa Wills; Ho Jun Yun; Yanna Tong; Lipeng Cai; Xiaokun Geng; Yuchuan Ding
Journal:  Front Neurol       Date:  2022-07-25       Impact factor: 4.086

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.